FDA Approved: LEVETIRACETAM — Supplemental Application (Solco healthcare U.S., LLC)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from Solco Healthcare U.S., LLC, enabling a generic version under ANDA203468.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)